N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial - Paydary, K; Akamaloo, A; Ahmadipour, A (J Clin Pharm Ther, 2016)
et al.